Proceedings of the National Academy of Sciences · 2013 · 117 citations · 31 references
Life SciencesMicrobiologyPharmacologyDrug DesignDrug DiscoveryLipid BiochemistryAntibacterial PharmacologyEnzyme InhibitionLipid BiosynthesisLipid Biosynthesis InhibitionLipid ChemistryResistance In Gram-positive BacteriaAntibiotic DiscoveryBacterial Membrane Lipid CompositionGlycerolipid BiosynthesisGlycerolipid SynthesisLipoteichoic Acid BiosynthesisNovel Antibacterial Drug DiscoveryResistance Mechanisms In Gram-positive BacteriaSmall Molecule Therapeutics
The current epidemic of infections caused by antibiotic-resistant gram-positive bacteria requires the discovery of new drug targets and the development of new therapeutics. Lipoteichoic acid (LTA), a cell wall polymer of gram-positive bacteria, consists of 1,3-polyglycerol-phosphate linked to glycolipid. LTA synthase (LtaS) polymerizes polyglycerol-phosphate from phosphatidylglycerol, a reaction that is essential for the growth of gram-positive bacteria. We screened small molecule libraries for compounds inhibiting growth of Staphylococcus aureus but not of gram-negative bacteria. Compound 1771 [2-oxo-2-(5-phenyl-1,3,4-oxadiazol-2-ylamino)ethyl 2-naphtho[2,1-b]furan-1-ylacetate] blocked phosphatidylglycerol binding to LtaS and inhibited LTA synthesis in S. aureus and in Escherichia coli expressing ltaS. Compound 1771 inhibited the growth of antibiotic-resistant gram-positive bacteria and prolonged the survival of mice with lethal S. aureus challenge, validating LtaS as a target for the development of antibiotics.
31
Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection · 2011 · 14K citations
Hung Ton‐That, Gwen Liu, Sarkis K. Mazmanian et al. · Proceedings of the National Academy of Sciences · 1999 · 572 citations · Full text